Homozigot ailevi hiperkolesterolemi: klinisyenlerin tanıyı ve klinik yönetimi geliştirmelerine yönelik yeni anlayışlar ve rehberlik. Avrupa Ateroskleroz Derneği’nin Ailevi Hiperkolesterolemi Üzerine Uzlaşı Paneli yazılı görüşüMarina Cuchel, M. John Chapman, Joep C. Defesche et al.|Unknown|2015Cited by 465
PCSK9 genetic variants and risk of type 2 diabetes: a mendelian randomisation studyAmand F. Schmidt, Andrzej Pająk, Daniel I. Swerdlow et al.|The Lancet Diabetes & Endocrinology|2016Cited by 390
The artificial sweetener erythritol and cardiovascular event riskMarco Witkowski, Stanley L. Hazen, Ina Nemet et al.|Nature Medicine|2023Cited by 205
Gut Microbiota-Generated Phenylacetylglutamine and Heart FailureKymberleigh A. Romano, Stanley L. Hazen, Ina Nemet et al.|Circulation Heart Failure|2022Cited by 150
A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease riskMarc Ferrell, Stanley L. Hazen, Zeneng Wang et al.|Nature Medicine|2024Cited by 124